What is Gabelli Healthcare & WellnessRx Trust Peter Lynch Fair Value?
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
GRX's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Asset Management industry.
Industry Median: 1.01 * Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Gabelli Healthcare & WellnessRx Trust Peter Lynch Fair Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Gabelli Healthcare & WellnessRx Trust Peter Lynch Fair Value Chart
Competitive Comparison of Gabelli Healthcare & WellnessRx Trust's Peter Lynch Fair Value
For the Asset Management subindustry, Gabelli Healthcare & WellnessRx Trust's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gabelli Healthcare & WellnessRx Trust's Price-to-Peter-Lynch-Fair-Value Distribution in the Asset Management Industry
For the Asset Management industry and Financial Services sector, Gabelli Healthcare & WellnessRx Trust's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Gabelli Healthcare & WellnessRx Trust's Price-to-Peter-Lynch-Fair-Value falls into.
Gabelli Healthcare & WellnessRx Trust Peter Lynch Fair Value Calculation
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gabelli Healthcare & WellnessRx Trust's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM Book Value Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data is the latest quarter data. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of Book Value per share over the past 5 years, which is 0 instead of 15 in this case.
Gabelli Healthcare & WellnessRx Trust's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
9.41
/
N/A
=
N/A
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gabelli Healthcare & WellnessRx Trust Peter Lynch Fair Value Related Terms
Thank you for viewing the detailed overview of Gabelli Healthcare & WellnessRx Trust's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least 80% of its assets in equity securities and income-producing securities of domestic & foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GRX has been successfully added to your 